IDT Biologika services

As one of the world’s leading CDMOs for vaccines, gene and immune therapeutics, and other biologics, IDT Biologika has a wealth of experience in the biological processes and technologies used to produce Viral Vaccines, Viral Vectors, and Oncolytic Viruses.

IDT Biologika is one of the world’s most experienced CDMOs in terms of expertise in developing and manufacturing of Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, Oncolytic Viruses, Virus-Like Particles, and other Biologics. We have GMP manufacturing facilities in Europe and the United States, offering capabilities from early-stage development through clinical to commercial scale. In Drug Substance Manufacturing, we provide master / working cell banks, master / working virus seeds, manufacture of bulk drug substance, and multiple manufacturing platforms. Working with our clients, we have been involved in the development and GMP manufacture of many of the world’s most notable vaccines developed over the last two decades.

To support our customers seeking to develop vaccines or looking for supplies of viral vectors, IDT Biologika works with several cell lines that are qualified according to current regulations, which means customers do not need to bring their own cell line. We can offer an optimal solution from cell lines proprietary to IDT Biologika or other non-proprietary ones that are commonly used in viral manufacturing. We can also transfer in a cell line that is already in use in a process.